Authentification abonné
lvrea
Accueil Tous les numéros Volume 24 (Janvier 2015) Supplément 2 Réanimation, 24 (2015) S304-S314 Références
Accès gratuit
Numéro
Réanimation
Volume 24, Janvier 2015
Page(s) S304 - S314
Section Session Thématique
DOI https://doi.org/10.1007/s13546-014-0940-7
Publié en ligne 12 février 2016
  • Magiorakos AP, Srinivasan A, Carey RB, et al (2012) Multidrugresistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 18:268–281 [CrossRef] [PubMed] [Google Scholar]
  • Aldeyab MA, Kearney MP, Hughes CM, et al (2009) Can the use of a rapid polymerase chain screening method decrease the incidence of nosocomial meticillin-resistant Staphylococcus aureus? J Hosp Infect 71:22–28 [CrossRef] [PubMed] [Google Scholar]
  • Harbarth S, Masuet-Aumatell C, Schrenzel J, et al (2006) Evaluation of rapid screening and pre-emptive contact isolation for detecting and controlling methicillin-resistant Staphylococcus aureus in critical care: an interventional cohort study. Crit Care 10:R25 [CrossRef] [PubMed] [Google Scholar]
  • Gazin M, Paasch F, Goossens H, et al (2012) Current trends in culture-based and molecular detection of extended-spectrum-betalactamase-harboring and carbapenem-resistant Enterobacteriaceae. J Clin Microbiol 50:1140–1146 [CrossRef] [PubMed] [Google Scholar]
  • Patel R (2013) Matrix-assisted laser desorption ionization-time of flight mass spectrometry in clinical microbiology. Clin Infect Dis 57:564–572 [CrossRef] [PubMed] [Google Scholar]
  • Haut Conseil de la Santé Publique (2013) Recommandations pour la prévention de la transmission croisée des bactéries hautement résistantes aux antibiotiques émergentes (BHRe). http://www.hcsp.fr/explore.cgi/avisrapportsdomaine?clefr=372 [Google Scholar]
  • Société Française d’Hygiène Hospitalière (SF2H) (2009) Prévention de la transmission croisée: précautions complémentaires contact. http://www.sf2h.net/publications-SF2H/SF2H_preventiontransmission-croisee-2009.pdf [Google Scholar]
  • Leclercq R, Derlot E, Duval J, et al (1988) Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium. N Engl J Med 319:157–161 [CrossRef] [PubMed] [Google Scholar]
  • European Centers for Disease Prevention and Control (2013) Antimicrobial Resistance Surveillance in Europe, 2012. Annual Report of the European Antimicrobial Surveillance Network (EARS-Net). ECDC, Stockholm, http://ecdc.europa.eu/en/publications/Publications/antimicrobial-resistance-surveillance-europe-2012.pdf [Google Scholar]
  • Fournier S, Brossier F, Fortineau N, et al (2012) Long-term control of vancomycin-resistant Enterococcus faecium at the scale of a large multihospital institution: a seven-year experience. Euro Surveill 17:pii:20229 [Google Scholar]
  • Munoz-Price LS, Poirel L, Bonomo RA, et al (2013) Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases. Lancet Infect Dis 13:785–796 [CrossRef] [PubMed] [Google Scholar]
  • Carmeli Y, Akova M, Cornaglia G, et al (2010) Controlling the spread of carbapenemase-producing Gram-negatives: therapeutic approach and infection control. Clin Microbiol Infect 16:102–111 [CrossRef] [PubMed] [Google Scholar]
  • Nordmann P, Nass T, Poirel L (2011) Global spread of carbapenemase-producing Enterobacteriaceae. Emerg Infect Dis 17:1791–1798 [CrossRef] [PubMed] [Google Scholar]
  • Tabah A, Koulenti D, Laupland K, et al (2012) Characteristics and determinants of outcome of hospital-acquired bloodstream infections in intensive care units: the EUROBACT International Cohort Study. Intensive Care Med 38:1930–1945 [CrossRef] [PubMed] [Google Scholar]
  • Institut de Veille Sanitaire (2014) Épisodes impliquant des entérobactéries productrices de carbapénèmases en France. Situation épidémiologique du 14 mars 2014. Institut de Veille Sanitaire, Saint-Maurice http://www.invs.sante.fr/Dossiers-thematiques/Maladies-infectieuses/Infections-associees-aux-soins/Surveillance-des-infections-associees-aux-soins-IAS/Enterobacteries-productrices-de-carbapenemases-EPC/Episodes-impliquant-des-enterobacteries-productrices-de-carbapenemases-en-France.-Situation-epidemiolo-gique-du-14-mars-2014 [Google Scholar]
  • Dortet L, Poirel L, Nordmann P (2014) Rapid detection of extended-spectrum beta-lactamase-producing Enterobacteriaceae from urine using the ESBL NDP test. J Clin Microbiol 52:3701–3706 [CrossRef] [PubMed] [Google Scholar]
  • Dortet L, Brechard L, Cuzon G, et al (2014) Strategy for rapid detection of carbapenemase-producing Enterobacteriaceae. Antimicrob Agents Chemother 58:2441–2445 [CrossRef] [PubMed] [Google Scholar]
  • Girlich D, Poirel L, Nordmann P (2013) Comparison of the SUPERCARBA, CHROMagar KPC, and Brilliance CRE screening media for detection of Enterobacteriaceae with reduced susceptibility to carbapenems. Diagn Microbiol Infect Dis 75:214–217 [CrossRef] [Google Scholar]
  • Fournier S, Monteil C, Lepainteur M, et al (2014) Long-term control of carbapenemase-producing Enterobacteriaceae at the scale of a large French multihospital institution: a nine-year experience, France 2004 to 2012. Euro Surveill 19:pii:20802 [CrossRef] [PubMed] [Google Scholar]
  • Landelle C, Legrand P, Lesprit P, et al (2013) Protracted outbreak of multidrug-resistant Acinetobacter baumannii after intercontinental transfer of colonized patients. Infect Control Hosp Epidemiol 34:119–124 [CrossRef] [PubMed] [Google Scholar]
  • Tankovic J, Legrand P, de Gatines G, et al (1994) Characterisation of an hospital outbreak of imipenem-resistant Acinetobacter baumanii by phenotypic and genotypic typing methods. J Clin Microbiol 32:2677–2681 [PubMed] [Google Scholar]
  • Naas T, Coignard B, Carbonne A, et al (2006) VEB-1 Extendedspectrum beta-lactamase-producing Acinetobacter baumannii, France. Emerg Infect Dis 12:1214–1222 [CrossRef] [PubMed] [Google Scholar]
  • Tacconelli E, Cataldo MA, Dancer SJ, et al (2014) ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant Gram-negative bacteria in hospitalized patients. Clin Microbiol Infect 20 Suppl 1:1–55 [CrossRef] [Google Scholar]
  • Jevons MP (1961) « Celbenin »-resistant staphylococci. Br Med J I:124–125 [CrossRef] [Google Scholar]
  • Rosdahl VT, Knudsen AM (1991) The decline of methicillin resistance among Danish Staphylococcus aureus strains. Infect Control Hosp Epidemiol 12:83–88 [CrossRef] [PubMed] [Google Scholar]
  • Wertheim HF, Vos MC, Boelens HA, et al (2004) Low prevalence of methicillin-resistant Staphylococcus aureus (MRSA) at hospital admission in the Netherlands: the value of search and destroy and restrictive antibiotic use. J Hosp Infect 56:321–325 [CrossRef] [PubMed] [Google Scholar]
  • Voss A, Milatovic D, Wallrauch-Schwartz C, et al (1994) Methicillin-resistant Staphylococcus aureus in Europe. Eur J Clin Microbiol Infect Dis 13:50–55 [CrossRef] [PubMed] [Google Scholar]
  • Jarlier V, Trystram D, Brun-Buisson C, et al (2010) Curbing methicillin-resistant Staphylococcus aureus in 38 French hospitals through a 15-year institutional control program. Arch Intern Med 170:552–559 [CrossRef] [PubMed] [Google Scholar]
  • Ellington MJ, Hope R, Livermore DM, et al (2010) Decline of EMRSA-16 amongst methicillin-resistant Staphylococcus aureus causing bacteraemias in the UK between 2001 and 2007. J Antimicrob Chemother 65:446–448 [CrossRef] [PubMed] [Google Scholar]
  • Siegel JD, Rhinehart E, Jackson M, et al (2007) Management of multidrug-resistant organisms in healthcare settings, 2006. Am J Infect Control 35:S165–S193 [CrossRef] [PubMed] [Google Scholar]
  • Weber SG, Huang SS, Oriola S, et al (2007) Legislative mandates for use of active surveillance cultures to screen for methicillinresistant Staphylococcus aureus and vancomycin-resistant enterococci: Position statement from the Joint SHEA and APIC Task Force. Am J Infect Control 35:73–85 [CrossRef] [PubMed] [Google Scholar]
  • Robicsek A, Beaumont JL, Paule SM, et al (2008) Universal surveillance for methicillin-resistant Staphylococcus aureus in 3 affiliated hospitals. Ann Intern Med 148:409–418 [CrossRef] [PubMed] [Google Scholar]
  • Jain R, Kralovic SM, Evans ME, et al (2011) Veterans Affairs initiative to prevent methicillin-resistant Staphylococcus aureus infections. N Engl J Med 364:1419–1430 [CrossRef] [PubMed] [Google Scholar]
  • Gurieva T, Bootsma MC, Bonten MJ (2012) Successful Veterans Affairs initiative to prevent methicillin-resistant Staphylococcus aureus infections revisited. Clin Infect Dis 54:1618–1620 [CrossRef] [PubMed] [Google Scholar]
  • Huskins WC, Huckabee CM, O’Grady NP, et al (2011) Intervention to reduce transmission of resistant bacteria in intensive care. N Engl J Med 364:1407–1418 [CrossRef] [PubMed] [Google Scholar]
  • Girou E, Chai SH, Oppein F, et al (2004) Misuse of gloves: the foundation for poor compliance with hand hygiene and potential for microbial transmission? J Hosp Infect 57:162–169 [CrossRef] [PubMed] [Google Scholar]
  • Harris AD, Pineles L, Belton B, et al (2013) Universal glove and gown use and acquisition of antibiotic-resistant bacteria in the ICU: a randomized trial. JAMA 310:1571–1580 [PubMed] [Google Scholar]
  • Cepeda JA, Whitehouse T, Cooper B, et al (2005) Isolation of patients in single rooms or cohorts to reduce spread of MRSA in intensive-care units: prospective two-centre study. Lancet 365:295–304 [CrossRef] [PubMed] [Google Scholar]
  • Huang SS, Septimus E, Kleinman K, et al (2013) Targeted versus universal decolonization to prevent ICU infection. N Engl J Med 368:2255–2265 [CrossRef] [PubMed] [Google Scholar]
  • Derde LP, Cooper BS, Goossens H, et al (2014) Interventions to reduce colonisation and transmission of antimicrobial-resistant bacteria in intensive care units: an interrupted time series study and cluster randomised trial. Lancet Infect Dis 14:31–39 [CrossRef] [PubMed] [Google Scholar]
  • Edmond MB, Wenzel RP (2013) Screening inpatients for MRSA–case closed. N Engl J Med 368:2314–2315 [CrossRef] [PubMed] [Google Scholar]
  • Arnaud I., Jarlier V., Groupe de travail BMR-Raisin (2014) Surveillance des bactéries multirésistantes dans les établissements de santé Français: Données 2012. Institut de Veille Sanitaire, Saint-Maurice http://www.invs.sante.fr/Publications-et-outils/Rapports-et-syntheses/Maladies-infectieuses/2014/Surveillance-des-bacteries-multiresistantes-dans-les-etablissements-de-sante-francais [Google Scholar]
  • Liebana E, Carattoli A, Coque TM, et al (2013) Public health risks of enterobacterial isolates producing extended-spectrum betalactamases or AmpC beta-lactamases in food and food-producing animals: an EU perspective of epidemiology, analytical methods, risk factors, and control options. Clin Infect Dis 56:1030–1037 [CrossRef] [PubMed] [Google Scholar]
  • Frank C, Werber D, Cramer JP, et al (2011) Epidemic profile of Shiga-toxin-producing Escherichia coli O104:H4 outbreak in Germany. N Engl J Med 365:1771–1780 [CrossRef] [PubMed] [Google Scholar]
  • Kaier K, Frank U, Hagist C, et al (2009) The impact of antimicrobial drug consumption and alcohol-based hand rub use on the emergence and spread of extended-spectrum beta-lactamase-producing strains: a time-series analysis. J Antimicrob Chemother 63:609–614 [CrossRef] [PubMed] [Google Scholar]
  • Andremont A, Brun-Buisson C, Struelens M (2001) Evaluating and predicting the ecologic impact of antibiotics. Clin Microbiol Infect 7:1–6 [CrossRef] [Google Scholar]
  • Armand-Lefevre L, Angebault C, Barbier F, et al (2013) Emergence of imipenem-resistant gram-negative bacilli in intestinal flora of intensive care patients. Antimicrob Agents Chemother 57:1488–1495 [CrossRef] [PubMed] [Google Scholar]
  • Prevot M-H, Andremont A, Sancho-Garnier H, et al (1986) Epidemiology of intestinal colonization by members of the family Enterobacteriaceae resistant to cefotaxime in a hematologyoncology unit. Antimicrob Agents Chemother 30:945–947 [CrossRef] [PubMed] [Google Scholar]
  • Rice LB, Eckstein EC, DeVente J, et al (1996) Ceftazidimeresistant Klebsiella pneumoniae isolates recovered at the Cleveland Department of Veterans Affairs Medical Center. Clin Infect Dis 23:118–124 [CrossRef] [PubMed] [Google Scholar]
  • Haut Conseil de Santé Publique (2010) Recommandations relatives aux mesures à mettre en oeuvre pour prévenir l’émergence des entérobactéries BLSE et lutter contre leur dissémination. http://www.hcsp.fr/explore.cgi/avisrapportsdomaine?clefr=162 [Google Scholar]
  • Nicolas-Chanoine MH, Gruson C, Bialek-Davenet S, et al (2012) 10-Fold increase (2006–11) in the rate of healthy subjects with extended-spectrum beta-lactamase-producing Escherichia coli faecal carriage in a Parisian check-up centre. J Antimicrob Chemother 68:562–568 [CrossRef] [PubMed] [Google Scholar]
  • Reuland EA, Overdevest IT, Al Naiemi N, et al (2012) High prevalence of ESBL-producing Enterobacteriaceae carriage in Dutch community patients with gastrointestinal complaints. Clin Microbiol Infect 19:542–549 [CrossRef] [PubMed] [Google Scholar]
  • Harris AD, Kotetishvili M, Shurland S, et al (2007) How important is patient-to-patient transmission in extended-spectrum betalactamase Escherichia coli acquisition. Am J Infect Control 35:97–101 [CrossRef] [PubMed] [Google Scholar]
  • Hilty M, Betsch BY, Bogli-Stuber K, et al (2012) Transmission dynamics of extended-spectrum beta-lactamase-producing Enterobacteriaceae in the tertiary care hospital and the household setting. Clin Infect Dis 55:867–875 [Google Scholar]
  • Rodriguez-Bano J, Navarro MD, Romero L, et al (2006) Clinical and molecular epidemiology of extended-spectrum beta-lactamaseproducing Escherichia coli as a cause of nosocomial infection or colonization: implications for control. Clin Infect Dis 42:37–45 [CrossRef] [PubMed] [Google Scholar]
  • Tängdén T, Cars O, Melhus A, et al (2010) Foreign travel is a major risk factor for colonization with Escherichia coli producing CTX-M type extended spectrum betalactabases: a prospective study with Swedish volunteers. Antimicrob Agents Chemother 54:3564–3568 [CrossRef] [PubMed] [Google Scholar]
  • Stelfox H, Bates D, Redelmeier D (2003) Safety of patients isolated for infection control. JAMA 290:1899–1905 [CrossRef] [PubMed] [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.